Titration of anti-IL-5 biologics in severe asthma

As part of its August issue, the European Respiratory Journal presents the latest in its series of podcasts.

 

Deputy Chief Editor Don Sin interviews Marianne Baastrup Soendergaard (Department of Respiratory Medicine, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark) about the OPTIMAL study: an open-label randomised controlled trial of titration of anti-interleukin-5 biologic therapy in severe asthma.

 

Download

Listen on SoundCloud

Listen on Spotify

Listen on Apple Podcasts

Recent episodes

Watch previous episodes

Load more